1). Fishman JA. Infection in solid organ transplant recipients. N Engl J Med. 2007; 357:2601–14.
2). Park JS, Kim MS, Lee JH, Chang J, Kim SK, Jeon KO, et al. Mycobacterial infection after kidney transplantation: single center experience. J Korean Soc Transplant. 2001; 15:39–46. (박준성, 김명수, 이종훈, 장준, 김세규, 전경옥 등. 신장 이식 후 발생한 결핵에 관한 고찰. 대한이식학회지 2001;15: 39–46.).
3). Park SB, Suk J, Joo I, Kim HC, Cho WH, Park CH. Tuberculosis complicating kidney transplantation. J Korean Soc Transplant. 1995; 9:95–102. (박성배, 석준, 주일, 김현철, 조원현, 박철회. 신이식 후 발생한 결핵에 대한 고찰. 대한이식학회지 1995;9: 95–102.).
4). Kim MS, Byun CG, Lee KY, Kim SI, Kim SK, Chang J, et al. Mycobacterial infections after renal transplantation. J Korean Soc Transplant. 1995; 9:103–9. (김명수, 변창규, 이강영, 김순일, 김세규, 장준 등. 신장 이식 후 발생한 결핵. 대한이식학회지 1995;9: 103–9.).
5). The Korean National Tuberculosis Association (KNTA) [Internet]. Seoul: KNTA;2008. Available from:. http://www.knta.or.kr.
6). EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV. 7.2. Late infections. Tuberculosis. Nephrol Dial Transplant. 2002; 17(S4):39–43.
7). Sakhuja V, Jha V, Varma PP, Joshi K, Chugh KS. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation. 1996; 61:211–5.
Article
8). Jorgensen JO, Lalak NJ, Hunt DR. Is laparoscopy associated with a lower rate of postoperative adhesions than laparotomy? A comparative study in the rabbit. Aust N Z J Surg. 1995; 65:342–4.
Article
9). Schippers E, Tittel A, Ottinger A, Schumpelick V. Laparoscopy versus laparotomy: comparison of adhesion-formation after bowel resection in a canine model. Dig Surg. 1998; 15:145–7.
10). Apaydin B, Paksoy M, Bilir M, Zengin K, Saribeyoglu K, Taskin M. Value of diagnostic laparoscopy in tuberculous peritonitis. Eur J Surg. 1999; 165:158–63.
11). al Quorain AA, Satti MB, al Gindan YM, al Ghassab GA, al Freihi HM. Tuberculous peritonitis: the value of laparoscopy. Hepatogastroenterology. 1991; 38(S1):37–40.
12). Cassidy MJ, van Zyl-Smit R, Pascoe MD, Swanepoel CR, Jacobson JE. Effect of rifampicin on cyclosporin A blood levels in a renal transplant recipient. Nephron. 1985; 41:207–8.
Article
13). Offermann G, Keller F, Molzahn M. Low cyclosporin A blood levels and acute graft rejection in a renal transplant recipient during rifampin treatment. Am J Nephrol. 1985; 5:385–7.
Article
14). Vachharajani TJ, Oza UG, Phadke AG, Kirpalani AL. Tuberculosis in renal transplant recipients: rifampicin sparing treatment protocol. Int Urol Nephrol 2002–3;34:. 551–3.
Article
15). Lee SJ, Park JA, Chang YK, Choi BS, Yoon SA, Yang CW, et al. The treatment of post transplant tuberculosis: rifampin sparing regimen. J Korean Soc Transplant. 2009; 23:22–7. (이상주, 박진아, 장윤경, 최범순, 윤선애, 양철우 등. 신이식 후 발생한 결핵의 치료: Rifampin 제외 복합요법. 대한이식학회지 2009;23: 22–7.).
16). Kidney Disease. Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009; 9(S3):1–155.